For citations:
Totolyan NA, Alifirova VM, Bakhtiyarova KZ, Boyko AN, Vlasov YV, Goncharova ZA, Zakharova MN, Kasatkin DS, Kotov SV, Nilov AI, Sivertseva SA, Sokolova AA, Spirin NN, Khabirov FA, Paradnika D. Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):138-145. (In Russ.) https://doi.org/10.14412/2074-2711-2020-5-138-145
Email this article 